Embotelladora Andina S.A (AKO-B)
Official siteCONSUMER DEFENSIVE • BEVERAGES - NON-ALCOHOLIC • NYSE
Market Cap: $4.52B
Last updated: Nov 16, 2026 at 4:00 PM ET
Embotelladora Andina S.A (AKO-B) Financials: Revenue, Profit and Cash Flow
Embotelladora Andina S.A reported revenue of CLP 3.34T for the fiscal year ended Dec 31, 2025, up 3.7% from the year before. That year, net income was CLP 268.70B with a net margin of 8.0%, operating cash flow was CLP 461.13B and free cash flow was CLP 183.31B. The quarter ended Sep 30, 2026 had revenue of CLP 896.61B and net income of CLP 61.48B.
Revenue and Margins
The operating margin was 13.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from CLP 1.78T, a compound annual rate of 7.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | 3.34T | +3.7% | 39.1% | 13.4% | 8.0% |
| Dec 2024 | 3.22T | +23.1% | 39.7% | 12.8% | 7.2% |
| Dec 2023 | 2.62T | -1.4% | 38.8% | 13.6% | 6.5% |
| Dec 2022 | 2.66T | +19.9% | 38.7% | 13.1% | 4.7% |
| Dec 2021 | 2.22T | +30.5% | 38.0% | 12.6% | 7.0% |
| Dec 2020 | 1.70T | -4.5% | 39.8% | 14.1% | 7.2% |
| Dec 2019 | 1.78T | +6.3% | 41.1% | 13.4% | 9.8% |
| Dec 2018 | 1.67T | -9.5% | 42.1% | 13.2% | 5.8% |
| Dec 2017 | 1.85T | +4.0% | 42.2% | 12.5% | 6.4% |
| Dec 2016 | 1.78T | N/A | 41.8% | 11.7% | 5.1% |
Income Statement
In the fiscal year ended Dec 2025, net income rose 15.5% from the year before. In the quarter ended Sep 2026, net income rose 7.5% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.34T | 3.22T | 2.62T | 2.66T | 2.22T | 1.70T | 1.78T | 1.67T | 1.85T | 1.78T |
| Cost of revenue | 2.04T | 1.95T | 1.60T | 1.63T | 1.38T | 1.02T | 1.05T | 968.03B | 1.07T | 1.03T |
| Gross profit | 1.31T | 1.28T | 1.02T | 1.03T | 841.34B | 675.78B | 730.68B | 704.89B | 779.85B | 743.55B |
| Research and development | 6.63B | 11.20B | 3.52B | 4.86B | 2.59B | 1.80B | 2.70B | 1.50B | 1.23B | 1.51B |
| Operating income | 448.25B | 411.91B | 357.34B | 346.76B | 278.56B | 239.61B | 237.78B | 220.72B | 231.06B | 207.70B |
| Net income | 268.70B | 232.66B | 171.44B | 125.50B | 154.70B | 122.00B | 173.72B | 96.60B | 117.84B | 90.53B |
| EBITDA | N/A | 557.70B | 451.74B | 397.92B | 360.98B | 341.07B | 389.22B | 307.20B | 322.49B | 289.57B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 896.61B | 820.09B | 924.26B | 921.08B | 800.36B | 738.15B | 888.18B | 952.04B | 726.81B | 672.19B | 804.64B | 597.44B |
| Gross profit | 344.21B | 319.18B | 379.04B | 370.86B | 301.92B | 279.84B | 358.00B | 384.12B | 275.26B | 260.40B | 326.90B | 228.04B |
| Operating income | 100.49B | 87.32B | 148.97B | 140.27B | 90.26B | 79.87B | 130.15B | 148.88B | 78.59B | 63.46B | 115.61B | 105.85B |
| Net income | 61.48B | 37.26B | 99.26B | 97.09B | 57.18B | 37.23B | 79.22B | 99.68B | 41.94B | 24.60B | 70.81B | 59.29B |
Balance Sheet
As of Dec 2025, total debt of CLP 1.14T exceeded cash and equivalents by 845.28B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.42T | 3.29T | 2.92T | 3.01T | 2.95T | 2.45T | 2.39T | 2.21T | 2.11T | 2.20T |
| Current assets | 1.03T | 1.01T | 981.77B | 1.16T | 990.99B | 797.30B | 533.47B | 481.59B | 484.01B | 552.74B |
| Cash and equivalents | 296.54B | 248.90B | 303.68B | 291.68B | 304.31B | 309.53B | 157.57B | 137.54B | 136.24B | 141.26B |
| Total liabilities | 2.22T | 2.28T | 2.00T | 2.13T | 1.84T | 1.62T | 1.42T | 1.35T | 1.30T | 1.36T |
| Short-term debt | 45.25B | 95.83B | 38.91B | 348.56B | 33.60B | 25.22B | 29.06B | 43.74B | 53.69B | 50.13B |
| Long-term debt | 1.10T | 1.00T | 967.06B | 776.73B | 1.02T | 922.92B | 719.87B | 702.77B | 661.29B | 703.42B |
| Shareholder equity | 1.16T | 976.41B | 886.29B | 855.26B | 1.08T | 811.18B | 948.65B | 843.81B | 791.31B | 820.61B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.78T | 3.49T | 3.54T | 3.48T | 3.38T | 3.11T | 3.12T | 3.29T | 3.02T | 3.00T | 3.12T | 2.92T |
| Total liabilities | 2.36T | 2.13T | 2.13T | 2.28T | 2.21T | 2.00T | 2.05T | 2.28T | 2.02T | 1.94T | 1.97T | 2.00T |
| Cash and equivalents | 435.77B | 322.08B | 373.15B | 296.54B | 282.83B | 207.58B | 208.48B | 248.90B | 210.69B | 232.43B | 301.52B | 303.68B |
| Shareholder equity | 1.38T | 1.32T | 1.37T | 1.16T | 1.14T | 1.07T | 1.03T | 976.41B | 969.38B | 1.03T | 1.12T | 886.29B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 39.8% of operating cash flow. Dividends came to 106.9% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 461.13B | 357.24B | 366.83B | 125.50B | 305.05B | 278.77B | 255.15B | 96.60B | 117.84B | 215.51B |
| Capital expenditures | 277.82B | 291.54B | 192.71B | 186.70B | 144.03B | 86.08B | 111.13B | 121.06B | 180.78B | 128.22B |
| Free cash flow | 183.31B | 65.70B | 174.12B | -61.20B | 161.03B | 192.69B | 144.02B | -24.46B | -62.95B | 87.30B |
| Dividends paid | 195.89B | 158.41B | 165.88B | 274.32B | 106.35B | 99.99B | 86.27B | 87.54B | 74.97B | 67.59B |
| Investing cash flow | -248.58B | -289.85B | -158.29B | -85.17B | -198.25B | -223.88B | -110.05B | -118.09B | -168.83B | -113.92B |
| Financing cash flow | -162.41B | -119.76B | -187.13B | -286.96B | -115.32B | 113.04B | -127.11B | -114.64B | -78.35B | -98.22B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 75.20B | 148.77B | 89.38B | 199.09B | 90.03B | 54.97B | 101.71B | 138.99B | 72.13B | 73.19B | 72.94B | 168.43B |
| Capital expenditures | 61.82B | 41.31B | 53.96B | 78.07B | 80.41B | 47.85B | 64.38B | 210.51B | 62.94B | 62.70B | 62.70B | 41.55B |
| Free cash flow | 13.38B | 107.45B | 35.41B | 121.02B | 9.62B | 7.11B | 37.33B | -71.52B | 9.19B | 10.49B | 10.24B | 126.89B |
Frequently Asked Questions About AKO-B
What is Embotelladora Andina S.A's annual revenue?
Embotelladora Andina S.A reported revenue of CLP 3.34T for the fiscal year ended Dec 31, 2025.
How fast is Embotelladora Andina S.A's revenue growing?
Revenue was up 3.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 8.0%.
Is Embotelladora Andina S.A profitable?
Yes. Embotelladora Andina S.A reported net income of CLP 268.70B for the fiscal year ended Dec 31, 2025, with a net margin of 8.0%.
How much free cash flow does AKO-B generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of CLP 461.13B minus capital expenditures of CLP 277.82B produced free cash flow of CLP 183.31B.
How much debt does Embotelladora Andina S.A have?
The balance sheet dated Dec 31, 2025 reported long-term debt of CLP 1.10T, short-term debt of CLP 45.25B and cash and equivalents of CLP 296.54B.
AKO-B pages: Overview, Dividends, Financials, Valuation, Competitors